Stockchase Opinions

John O'Connell, CFA Concordia Healthcare Corp CXRX-Q TOP PICK May 03, 2016

This has grown by acquisition, buying a lot of drugs. They sell drugs to over 100 companies. Generates EBITDA of around $600 million. Have $3.5 billion of debt. They free cash flow $300 million a year which they can pay down the debt with. Thinks there is a very good chance this company will not be public in a couple of weeks. Dividend yield of 1.14%.

$26.420

Stock price when the opinion was issued

Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK

(A Top Pick May 3/16. Down 95%.) This was a mistake. There are shareholder lawsuits involved. It was growth by acquisition, and it looks like they dramatically overpaid for some assets. They got involved with generic competition, and as well, the perfect storm of politics of the last election really killed the stock.